Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 30 (MTND5P30) is classified as a pseudogene, which is a DNA sequence resembling a functional gene but lacking the capability to encode a functional protein[2][4][6]. It is a nuclear DNA sequence related to the mitochondrial gene MT-ND5, which encodes a subunit of Complex I, a key enzyme in mitochondrial oxidative phosphorylation[1][3][5]. However, pseudogenes such as MTND5P30 do not contribute to the function of Complex I and are not therapeutic targets, disease-related genes, or functional biomarkers[2][5][6]. MTND5P30 is often referenced in genome databases (NCBI Gene ID: 100873266, HGNC: 42292) strictly as a pseudogene[2][6]. There is no evidence in the literature or databases of a protein product, involvement in biological pathways, disease association, drug targeting, or relevance as a biomarker[2][4][6]. Reports of pseudogenes for mitochondrial genes support their existence in nuclear DNA but emphasize that mutations or expression of these pseudogenes do not produce functional mitochondrial proteins, nor do they compensate for mitochondrial gene defects[5]. MT-ND5P30 is sometimes erroneously treated as a potential functional target, but it is not considered a therapeutic target or relevant in the context of receptor, enzyme, transporter, or drug activity research[2][5][6]. There are no known drugs or mechanisms acting on this pseudogene. If encountered in target lists for therapeutic discovery, it should be flagged as a non-functional pseudogene, not as a druggable protein or receptor[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 30 (MTND5P30).